These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 9518648

  • 1. Protection against blood-brain barrier disruption in focal cerebral ischemia by the type IV phosphodiesterase inhibitor BBB022: a quantitative study.
    Belayev L, Busto R, Ikeda M, Rubin LL, Kajiwara A, Morgan L, Ginsberg MD.
    Brain Res; 1998 Mar 23; 787(2):277-85. PubMed ID: 9518648
    [Abstract] [Full Text] [Related]

  • 2. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats.
    Belayev L, Busto R, Zhao W, Ginsberg MD.
    Brain Res; 1996 Nov 11; 739(1-2):88-96. PubMed ID: 8955928
    [Abstract] [Full Text] [Related]

  • 3. Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors.
    Folcik VA, Smith T, O'Bryant S, Kawczak JA, Zhu B, Sakurai H, Kajiwara A, Staddon JM, Glabinski A, Chernosky AL, Tani M, Johnson JM, Tuohy VK, Rubin LL, Ransohoff RM.
    J Neuroimmunol; 1999 Jun 01; 97(1-2):119-28. PubMed ID: 10408965
    [Abstract] [Full Text] [Related]

  • 4. Neuroprotection by LY341122, a novel inhibitor of lipid peroxidation, against focal ischemic brain damage in rats.
    Huh PW, Belayev L, Zhao W, Clemens JA, Panetta JA, Busto R, Ginsberg MD.
    Eur J Pharmacol; 2000 Feb 11; 389(1):79-88. PubMed ID: 10686299
    [Abstract] [Full Text] [Related]

  • 5. Focal cerebral ischemic tolerance and change in blood-brain barrier permeability after repetitive pure oxygen exposure preconditioning in a rodent model.
    Wang X, Kang K, Wang S, Yao J, Zhang X.
    J Neurosurg; 2016 Oct 11; 125(4):943-952. PubMed ID: 26824373
    [Abstract] [Full Text] [Related]

  • 6. MRZ 2/579, a novel uncompetitive N-methyl-D-aspartate antagonist, reduces infarct volume and brain swelling and improves neurological deficit after focal cerebral ischemia in rats.
    Liu Y, Belayev L, Zhao W, Busto R, Ginsberg MD.
    Brain Res; 2000 Apr 17; 862(1-2):111-9. PubMed ID: 10799675
    [Abstract] [Full Text] [Related]

  • 7. Hydrogen sulfide protects blood-brain barrier integrity following cerebral ischemia.
    Wang Y, Jia J, Ao G, Hu L, Liu H, Xiao Y, Du H, Alkayed NJ, Liu CF, Cheng J.
    J Neurochem; 2014 Jun 17; 129(5):827-38. PubMed ID: 24673410
    [Abstract] [Full Text] [Related]

  • 8. A selective endothelin ET(A) receptor antagonist, SB 234551, improves cerebral perfusion following permanent focal cerebral ischemia in rats.
    Zhang Y, Belayev L, Zhao W, Irving EA, Busto R, Ginsberg MD.
    Brain Res; 2005 May 31; 1045(1-2):150-6. PubMed ID: 15910773
    [Abstract] [Full Text] [Related]

  • 9. Effects of a phosphodiesterase IV inhibitor rolipram on microsphere embolism-induced defects in memory function and cerebral cyclic AMP signal transduction system in rats.
    Nagakura A, Niimura M, Takeo S.
    Br J Pharmacol; 2002 Apr 31; 135(7):1783-93. PubMed ID: 11934820
    [Abstract] [Full Text] [Related]

  • 10. Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage.
    Liu XF, Fawcett JR, Thorne RG, DeFor TA, Frey WH.
    J Neurol Sci; 2001 Jun 15; 187(1-2):91-7. PubMed ID: 11440750
    [Abstract] [Full Text] [Related]

  • 11. Phosphodiesterase type 4 inhibitor prevents acute lung injury induced by cardiopulmonary bypass in a rat model.
    Hamamoto M, Suga M, Nakatani T, Takahashi Y, Sato Y, Inamori S, Yagihara T, Kitamura S.
    Eur J Cardiothorac Surg; 2004 May 15; 25(5):833-8. PubMed ID: 15082290
    [Abstract] [Full Text] [Related]

  • 12. Rolipram, a phosphodiesterase 4 inhibitor, prevented cancellous and cortical bone loss by inhibiting endosteal bone resorption and maintaining the elevated periosteal bone formation in adult ovariectomized rats.
    Yao W, Tian XY, Chen J, Setterberg RB, Lundy MW, Chmielzwski P, Froman CA, Jee WS.
    J Musculoskelet Neuronal Interact; 2007 May 15; 7(2):119-30. PubMed ID: 17627081
    [Abstract] [Full Text] [Related]

  • 13. Blood brain barrier breakdown was found in non-infarcted area after 2-h MCAO.
    Wang X, Liu Y, Sun Y, Liu W, Jin X.
    J Neurol Sci; 2016 Apr 15; 363():63-8. PubMed ID: 27000223
    [Abstract] [Full Text] [Related]

  • 14. The effect of bone morphogenetic protein-7 (BMP-7) on functional recovery, local cerebral glucose utilization and blood flow after transient focal cerebral ischemia in rats.
    Liu Y, Belayev L, Zhao W, Busto R, Saul I, Alonso O, Ginsberg MD.
    Brain Res; 2001 Jun 29; 905(1-2):81-90. PubMed ID: 11423082
    [Abstract] [Full Text] [Related]

  • 15. Alpha-Tocopherol Reduces Brain Edema and Protects Blood-Brain Barrier Integrity following Focal Cerebral Ischemia in Rats.
    Haghnejad Azar A, Oryan S, Bohlooli S, Panahpour H.
    Med Princ Pract; 2017 Jun 29; 26(1):17-22. PubMed ID: 27606423
    [Abstract] [Full Text] [Related]

  • 16. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P, Prigent AF, Lagarde M, Nemoz G.
    Mol Pharmacol; 1993 Nov 29; 44(5):1027-35. PubMed ID: 8246905
    [Abstract] [Full Text] [Related]

  • 17. Alterations in [3H]MK-801, [3H]muscimol, [3H]cyclic AMP, and [3H]rolipram binding in the gerbil hippocampus following repeated ischemic insults.
    Kato H, Araki T, Murase K, Kogure K.
    Neuroscience; 1993 Jan 29; 52(2):245-53. PubMed ID: 8383818
    [Abstract] [Full Text] [Related]

  • 18. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE, Lugnier C.
    Br J Pharmacol; 1994 Oct 29; 113(2):445-50. PubMed ID: 7834194
    [Abstract] [Full Text] [Related]

  • 19. Intra-artery infusion of recombinant human erythropoietin reduces blood-brain barrier disruption in rats following cerebral ischemia and reperfusion.
    Wang R, Wu X, Liang J, Qi Z, Liu X, Min L, Ji X, Luo Y, Zhao H.
    Int J Neurosci; 2015 Oct 29; 125(9):693-702. PubMed ID: 25226558
    [Abstract] [Full Text] [Related]

  • 20. 2-(2-Benzofuranyl)-2-Imidazoline Mediates Neuroprotection by Regulating the Neurovascular Unit Integrity in a Rat Model of Focal Cerebral Ischemia.
    Zhang Z, Zhang L, Chen J, Cao Y, Qu M, Lin X, Han Z, Ji X.
    J Stroke Cerebrovasc Dis; 2018 Jun 29; 27(6):1481-1489. PubMed ID: 29398538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.